Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 302 followers
Latest posts
Last updated about 8 hours ago
Q&A clinic on eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) service, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 18 November 2025, 14:00 (CET) to 18 November 2025, 15:00 (CET)
about 9 hours ago
Q&A clinic on eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) service, Online, European...
CAT quarterly highlights and approved ATMPs - December 2025
about 9 hours ago
CAT quarterly highlights and approved ATMPs - December 2025
Opinion on medicine for use outside EU: Aluvia, lopinavir,ritonavir, HIV Infections, 21/09/2006 Positive opinion
about 9 hours ago
Opinion on medicine for use outside EU: Aluvia, lopinavir,ritonavir, HIV Infections, 21/09/2006...
Outcomes of imposed non-interventional post-authorisation safety studies
about 9 hours ago
Outcomes of imposed non-interventional post-authorisation safety studies
Human medicines European public assessment report (EPAR): Kaletra, lopinavir,ritonavir, Date of authorisation: 19/03/2001, Revision: 65, Status: Authorised
about 9 hours ago
Human medicines European public assessment report (EPAR): Kaletra, lopinavir,ritonavir, Date of authorisation...
Human medicines European public assessment report (EPAR): Pregabalin Sandoz, pregabalin, Date of authorisation: 19/06/2015, Revision: 23, Status: Authorised
about 10 hours ago
Human medicines European public assessment report (EPAR): Pregabalin Sandoz, pregabalin, Date of...
Human medicines European public assessment report (EPAR): Mysildecard, sildenafil, Date of authorisation: 15/09/2016, Revision: 10, Status: Authorised
about 10 hours ago
Human medicines European public assessment report (EPAR): Mysildecard, sildenafil, Date of authorisation...
Human medicines European public assessment report (EPAR): Gilenya, fingolimod, Date of authorisation: 17/03/2011, Revision: 40, Status: Authorised
about 10 hours ago
Human medicines European public assessment report (EPAR): Gilenya, fingolimod, Date of authorisation...
Human medicines European public assessment report (EPAR): Tevimbra, tislelizumab, Date of authorisation: 15/09/2023, Revision: 15, Status: Authorised
about 10 hours ago
Human medicines European public assessment report (EPAR): Tevimbra, tislelizumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Krazati, adagrasib, Date of authorisation: 05/01/2024, Revision: 3, Status: Authorised
about 13 hours ago
Human medicines European public assessment report (EPAR): Krazati, adagrasib, Date of authorisation...
Human medicines European public assessment report (EPAR): Upstaza, eladocagene exuparvovec, Date of authorisation: 18/07/2022, Revision: 9, Status: Authorised
about 13 hours ago
Human medicines European public assessment report (EPAR): Upstaza, eladocagene exuparvovec, Date of...